Washington, DC, United States May 18, 2024 - May 21, 2024 Follow your own path at Digestive Disease Week® (DDW), the world’s premier gathering of gastroenterology clinicians, researchers and industry. Visit the conference website for more details. ...
Urinary-Neutrophil Gelatinase-Associated Lipocalin (u-NGAL) as a predictor of Acute Kidney Injury in post-liver transplant recipients Estimation of Serum Leptin Levels in Patients with chronic hepatitis C (CHC) Peptic ulcer disease in children, an experience from north of Jordan...
Welcome to the 2024 Korea Digestive Disease Week (KDDW 2024), proudly hosted by Korean Society of Gastrointestinal Endoscopy (KSGE). Set against the backdrop of the Grand Walkerhill Seoul in South Korea, from November 14th to 16th, 2024, this event is a collaborative effort among esteemed org...
7 people interested. Check out who is attending ✭ exhibiting ✭ speaking ✭ schedule & agenda ✭ reviews ✭ timing ✭ entry ticket fees. 2024 edition of Digestive Disease Week will be held at Washington DC starting on 18th MayEs un evento de
The 8th Korea Digestive Disease Week (KDDW 2024) Date: November 14-16, 2024 Venue: Grand Walkerhill Seoul, in Seoul, Korea Hosted by: Organizing Committee of the 7th Korea Digestive Disease Week Supported by (Member Societies): The Korean Society of Gastroenterology ...
24 people interested. Rated 5.0 by 2 people. Check out who is attending ✭ exhibiting ✭ speaking ✭ schedule & agenda ✭ reviews ✭ timing ✭ entry ticket fees. 2024 edition of Japan Digestive Disease Week will be held at Kobe Convention Cen
Digestive Disease Week (DDW 2025), 03-06 May 2025, San Diego, United States, organized by AGA Institute - American Gastroenterological Association. Find conference details | Conference Locate (Clocate)
Digestive Disease Week® (DDW) will be held May 18-21, 2024, in Washington, DC. This annual event serves as the leading gathering for gastroenterologists, researchers, and industry professionals. We outline some of the essential sessions at DDW focused
today announced that data supporting additional positive clinical observations of IBSRELA®(tenapanor) was presented at the 2024 Digestive Disease Week Conference (DDW), currently taking place in Washington, D.C. IBSRELA is a first-in-class treatment that is approved by the U.S. Food and Drug...
Entero Therapeutics, Inc. yesterday presented two posters on celiac disease research at the 2024 Digestive Disease Week (DDW 2024) Conference in Washington, D.C.